Eveline Boucher is a certified physician in gastroenterology, hepatology and oncology. She got her medical and scientific degrees from Rennes and Paris VI universities. HCP for 19 years (1996-2015) at the Comprehensive cancer Center in Rennes. She entered a Pharma company in 2015 (Nanobiotix a French biotech Company) as a Medical Director for clinical operations. She joined BTG/BSC in March 2017 in the medical affairs - Interventional Oncology unit, with the role of providing medical input for oncology business and strategy, and to support pharmacovigilance, information, education and regulatory teams. Since Dec 2021 joined the medical safety group for safety oversight in interventional oncology products within their life cycle and within clinical trial development. She is a member of the BSC New Technology accelerator group aimed to develop new product and indication with BSC products